KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Non-Current Liabilities (2019 - 2026)

Castle Biosciences' Other Non-Current Liabilities history spans 6 years, with the latest figure at $1.5 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a N/A change, with the full-year FY2025 number at $1.5 million, changed N/A from a year prior.
  • Other Non-Current Liabilities hit $1.5 million in Q4 2025 for Castle Biosciences, roughly flat from $1.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CSTL hit a ceiling of $18.3 million in Q4 2021 and a floor of $3000.0 in Q3 2021.
  • Historically, Other Non-Current Liabilities has averaged $1.7 million across 5 years, with a median of $95000.0 in 2022.
  • The widest YoY moves for Other Non-Current Liabilities: up 59833.33% in 2022, down 99.51% in 2022.
  • Tracing CSTL's Other Non-Current Liabilities over 5 years: stood at $18.3 million in 2021, then plummeted by 99.51% to $90000.0 in 2022, then plummeted by 72.22% to $25000.0 in 2023, then tumbled by 36.0% to $16000.0 in 2024, then surged by 9275.0% to $1.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CSTL at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.